Maxwell Steeples

Maxwell Steeples currently serves as a Scientist I at Nimble Therapeutics, where he plays a pivotal role in the development and validation of analytical methods for a diverse range of biopharmaceutical compounds. His expertise lies primarily in high-performance liquid chromatography (HPLC), ultra-performance liquid chromatography (UPLC), and capillary electrophoresis, ensuring that all processes adhere to stringent internal standard operating procedures (SOPs) and current Good Manufacturing Practices (cGMP). Maxwell is particularly adept at analyzing peptidic activity on arrays and developing peptide assays off-array using enzyme-linked immunosorbent assay (ELISA) techniques.

In his role, he is responsible for generating and interpreting complex datasets using R programming, which enhances the analytical capabilities of the laboratory and supports data-driven decision-making. His proficiency in method development and troubleshooting of chromatography techniques has been instrumental in optimizing laboratory workflows and improving the reliability of results. Maxwell thrives in collaborative environments, valuing the synergy that comes from working with like-minded colleagues who share a commitment to scientific excellence.

His skill set extends beyond technical expertise; Maxwell is proficient in utilizing software tools such as Empower for data analysis and Microsoft Office for documentation and reporting. This combination of analytical skills and collaborative spirit positions him as a valuable asset to Nimble Therapeutics, where he contributes to advancing biopharmaceutical innovations that can significantly impact patient outcomes.